Protective Effects of EPI-743 on Noise-Induced Hearing Loss
Completed · Phase 2 · Has a placebo group
Conditions studied: Noise-induced Hearing Loss
In brief
If effective, administration of EPI-743 should have protective effects against temporary noise-induced hearing loss.
Key facts
- Study ID
- NCT02257983
- Run by
- Edison Pharmaceuticals Inc
- People needed
- 77
- Starts
- 2014-10-31
- Expected to finish
- 2016-02-29
- Last updated by the study team
- 2020-11-18
Who can join
Age: 18 and older, up to 30. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy adults ages 18-30
- Abstention from use of Idebenone, CoQ10, Vitamin E and foods or beverages at least 30 days prior to treatment initiation
- Non-smokers
- Abstention from alcohol from day 0 and throughout the duration of study
- Normal audiology exam
- Subject must be able to swallow size 0 capsules
You may not qualify if…
- Allergy to EPI-743 or sesame oil or nuts
- Any medical disordere that would prevent subject participation
- Any prescription meds other than for contraception or seasonal allergies
- Any significant patient medical history (cancer, cardiovascular, pulmonary, cognitive, ADHD, hx. of migraines, neurological, kidney)
- Fat malabsorption syndromes
- Anticoagulation thereapy within 30 days of enrollment
Where it is running
- University of Florida — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.